Brief: Microbix & Seegene Canada Form Covid-Variant Collaboration
March 15 (Reuters) - Microbix Biosystems Inc MBX.TO :
* MICROBIX & SEEGENE CANADA FORM COVID-VARIANT COLLABORATION
* MICROBIX BIOSYSTEMS - SEEGENE CANADA WILL DISTRIBUTE,
RECOMMEND
CO'S NEW COVID-VARIANT QUALITY ASSESSMENT PRODUCTS
* MICROBIX BIOSYSTEMS - CO'S NOVEL COVID-VARIANT QAPS WILL
MONITOR
WORKFLOW ACCURACY AND LABORATORY TESTING PERFORMANCE OF ASSAYS
Source text for Eikon: ID:nGNXb1q51Z
Further company coverage: MBX.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microbix Biosystems
See all newsCanada's Microbix Q3 revenue rises on higher antigen, QAPs sales
Brief: Microbix Biosystems Q3 Revenue CAD 4.1 Million
Canada's Microbix Biosystems Q2 revenue falls 37% on weaker China sales
Canada's Microbix Q1 revenue down 30% on China sales decline
Brief: Microbix Biosystems Q1 Revenue CAD 4.2 Million